Minimally-invasive innovative interspinous device delivers 99.6% success: Multicenter study

Conducted across 3 medical centres, an innovative percutaneous interspinous device (PID) promises remarkable relief for patients suffering from neurogenic claudication due to lumbar central canal and/or foraminal stenosis, as per the outcomes of a Retrospective multicenter study issued in ‘Spinal Neuroradiology’.

A total of 255 patients (aged 49 to 91 years old) were enrolled, with an overwhelming majority experiencing significant improvements in their condition. The procedure boasts an impressive success rate of 99.6%, with only 1 device out of 258 failing to be implanted due to a spinous process fracture.

What sets this method apart is its minimally invasive nature, performed under local anaesthesia and mild sedation with fluoroscopic guidance. This device, once correctly placed, offers relief without the need for major surgery. Additionally, 172 preventive spinoplasties were conducted, constituting 59.3% of the procedures without major complications, further highlighting the safety of the procedure.

Perhaps most encouragingly, 99.6% of patients reported clinical improvement afterwards, underscoring its potential to revolutionize the management of degenerative lumbar spinal stenosis.